✦ LIBER ✦

128 Achromobacter (A.) xylosoxidans in cystic fibrosis: Prevalence and clinical relevance

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Achromobacter xylosoxidans in cystic fib

✍ Frans De Baets; Petra Schelstraete; Sabine Van Daele; Filomeen Haerynck; Mario V 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Clinical relevance of Achromobacter xylo

✍ P. Dentini; K. Fiolo; J.D. Ribeiro; A.F. Ribeiro; L.M. Hollanda; M. Brocchi; C.E 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Achromobacter xylosoxidans induced bronc

✍ De Baets, F.; Schelstraete, P.; Haerynck, F.; Van Biervliet, S.; De Bruyne, R.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Achromobacter xylosoxidans respiratory t

✍ TIZIANA RASO; ORNELLA BIANCO; BIANCA GROSSO; MARIO ZUCCA; DIANELLA SAVOIA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Chronic infection with Achromobacter xyl

✍ Christine Rønne Hansen; Tacjana Pressler; Niels Høiby; Magdalena Gormsen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Epidemiology and resistance of Achromoba

✍ Amoureux, Lucie; Bador, Julien; Siebor, Eliane; Taillefumier, Nathalie; Fanton, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 143 KB